Cargando…

CD4(+)CD25(+) regulatory T cells decreased future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy

BACKGROUND: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is an innovative surgical approach for the treatment of massive hepatocellular carcinoma (HCC), the key to successful planned stage 2 ALPPS is future liver remnant (FLR) volume growth, but the exact mecha...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Ye, Chun-Hui, Deng, Zhen-Feng, Wang, Ji-Long, Zhang, Ling, Bao, Li, Xu, Bang-Hao, Zhu, Hai, Guo, Ya, Wen, Zhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277939/
https://www.ncbi.nlm.nih.gov/pubmed/37342857
http://dx.doi.org/10.4240/wjgs.v15.i5.917
_version_ 1785060389235458048
author Wang, Wei
Ye, Chun-Hui
Deng, Zhen-Feng
Wang, Ji-Long
Zhang, Ling
Bao, Li
Xu, Bang-Hao
Zhu, Hai
Guo, Ya
Wen, Zhang
author_facet Wang, Wei
Ye, Chun-Hui
Deng, Zhen-Feng
Wang, Ji-Long
Zhang, Ling
Bao, Li
Xu, Bang-Hao
Zhu, Hai
Guo, Ya
Wen, Zhang
author_sort Wang, Wei
collection PubMed
description BACKGROUND: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is an innovative surgical approach for the treatment of massive hepatocellular carcinoma (HCC), the key to successful planned stage 2 ALPPS is future liver remnant (FLR) volume growth, but the exact mechanism has not been elucidated. The correlation between regulatory T cells (Tregs) and postoperative FLR regeneration has not been reported. AIM: To investigate the effect of CD4(+)CD25(+) Tregs on FLR regeneration after ALPPS. METHODS: Clinical data and specimens were collected from 37 patients who developed massive HCC treated with ALPPS. Flow cytometry was performed to detect changes in the proportion of CD4(+)CD25(+) Tregs to CD4(+) T cells in peripheral blood before and after ALPPS. To analyze the relationship between peripheral blood CD4(+)CD25(+) Treg proportion and clinicopathological information and liver volume. RESULTS: The postoperative CD4(+)CD25(+) Treg proportion in stage 1 ALPPS was negatively correlated with the amount of proliferation volume, proliferation rate, and kinetic growth rate (KGR) of the FLR after stage 1 ALPPS. Patients with low Treg proportion had significantly higher KGR than those with high Treg proportion (P = 0.006); patients with high Treg proportion had more severe postoperative pathological liver fibrosis than those with low Treg proportion (P = 0.043). The area under the receiver operating characteristic curve between the percentage of Tregs and proliferation volume, proliferation rate, and KGR were all greater than 0.70. CONCLUSION: CD4(+)CD25(+) Tregs in the peripheral blood of patients with massive HCC at stage 1 ALPPS were negatively correlated with indicators of FLR regeneration after stage 1 ALPPS and may influence the degree of fibrosis in patients’ livers. Treg percentage was highly accurate in predicting the FLR regeneration after stage 1 ALPPS.
format Online
Article
Text
id pubmed-10277939
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-102779392023-06-20 CD4(+)CD25(+) regulatory T cells decreased future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy Wang, Wei Ye, Chun-Hui Deng, Zhen-Feng Wang, Ji-Long Zhang, Ling Bao, Li Xu, Bang-Hao Zhu, Hai Guo, Ya Wen, Zhang World J Gastrointest Surg Observational Study BACKGROUND: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is an innovative surgical approach for the treatment of massive hepatocellular carcinoma (HCC), the key to successful planned stage 2 ALPPS is future liver remnant (FLR) volume growth, but the exact mechanism has not been elucidated. The correlation between regulatory T cells (Tregs) and postoperative FLR regeneration has not been reported. AIM: To investigate the effect of CD4(+)CD25(+) Tregs on FLR regeneration after ALPPS. METHODS: Clinical data and specimens were collected from 37 patients who developed massive HCC treated with ALPPS. Flow cytometry was performed to detect changes in the proportion of CD4(+)CD25(+) Tregs to CD4(+) T cells in peripheral blood before and after ALPPS. To analyze the relationship between peripheral blood CD4(+)CD25(+) Treg proportion and clinicopathological information and liver volume. RESULTS: The postoperative CD4(+)CD25(+) Treg proportion in stage 1 ALPPS was negatively correlated with the amount of proliferation volume, proliferation rate, and kinetic growth rate (KGR) of the FLR after stage 1 ALPPS. Patients with low Treg proportion had significantly higher KGR than those with high Treg proportion (P = 0.006); patients with high Treg proportion had more severe postoperative pathological liver fibrosis than those with low Treg proportion (P = 0.043). The area under the receiver operating characteristic curve between the percentage of Tregs and proliferation volume, proliferation rate, and KGR were all greater than 0.70. CONCLUSION: CD4(+)CD25(+) Tregs in the peripheral blood of patients with massive HCC at stage 1 ALPPS were negatively correlated with indicators of FLR regeneration after stage 1 ALPPS and may influence the degree of fibrosis in patients’ livers. Treg percentage was highly accurate in predicting the FLR regeneration after stage 1 ALPPS. Baishideng Publishing Group Inc 2023-05-27 2023-05-27 /pmc/articles/PMC10277939/ /pubmed/37342857 http://dx.doi.org/10.4240/wjgs.v15.i5.917 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Observational Study
Wang, Wei
Ye, Chun-Hui
Deng, Zhen-Feng
Wang, Ji-Long
Zhang, Ling
Bao, Li
Xu, Bang-Hao
Zhu, Hai
Guo, Ya
Wen, Zhang
CD4(+)CD25(+) regulatory T cells decreased future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy
title CD4(+)CD25(+) regulatory T cells decreased future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy
title_full CD4(+)CD25(+) regulatory T cells decreased future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy
title_fullStr CD4(+)CD25(+) regulatory T cells decreased future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy
title_full_unstemmed CD4(+)CD25(+) regulatory T cells decreased future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy
title_short CD4(+)CD25(+) regulatory T cells decreased future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy
title_sort cd4(+)cd25(+) regulatory t cells decreased future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy
topic Observational Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277939/
https://www.ncbi.nlm.nih.gov/pubmed/37342857
http://dx.doi.org/10.4240/wjgs.v15.i5.917
work_keys_str_mv AT wangwei cd4cd25regulatorytcellsdecreasedfutureliverremnantafterassociatingliverpartitionandportalveinligationforstagedhepatectomy
AT yechunhui cd4cd25regulatorytcellsdecreasedfutureliverremnantafterassociatingliverpartitionandportalveinligationforstagedhepatectomy
AT dengzhenfeng cd4cd25regulatorytcellsdecreasedfutureliverremnantafterassociatingliverpartitionandportalveinligationforstagedhepatectomy
AT wangjilong cd4cd25regulatorytcellsdecreasedfutureliverremnantafterassociatingliverpartitionandportalveinligationforstagedhepatectomy
AT zhangling cd4cd25regulatorytcellsdecreasedfutureliverremnantafterassociatingliverpartitionandportalveinligationforstagedhepatectomy
AT baoli cd4cd25regulatorytcellsdecreasedfutureliverremnantafterassociatingliverpartitionandportalveinligationforstagedhepatectomy
AT xubanghao cd4cd25regulatorytcellsdecreasedfutureliverremnantafterassociatingliverpartitionandportalveinligationforstagedhepatectomy
AT zhuhai cd4cd25regulatorytcellsdecreasedfutureliverremnantafterassociatingliverpartitionandportalveinligationforstagedhepatectomy
AT guoya cd4cd25regulatorytcellsdecreasedfutureliverremnantafterassociatingliverpartitionandportalveinligationforstagedhepatectomy
AT wenzhang cd4cd25regulatorytcellsdecreasedfutureliverremnantafterassociatingliverpartitionandportalveinligationforstagedhepatectomy